Deciding on treatment for advanced cancer is overwhelming on your own.

Cancer Commons provides compassionate support as we identify and help you access the best diagnostic and treatment options.

We are unbiased and patient-centric. Our priority is you.

Over 10 years, we have helped thousands of advanced and metastatic cancer patients and caregivers with one-on-one support.

Our expert team is passionate about helping you find and understand your options. Together we will create a personalized plan of action you can share with your oncologist.

  • Webinar: Testing Matters—Understanding Cancer Biomarker Testing and How It Applies to You
    Testing Matters Webinar Recording Now Available

    Cancer Commons’ most recent webinar, Testing Matters—Understanding Cancer Biomarker Testing and How It Applies to You, was held virtually on September 14, 2022. During the webinar, Cancer Commons Scientists Kaumudi Bhawe, PhD, and Adrienne Nugent, PhD, provided plain-language explanations of different types of biomarker testing and described why, how, when, and where to access testing. They also answered audience questions. The webinar was the… Read more »

  • Pancreatic Cancer Action Network logo over Cancer Commons logo on a deep blue background
    Cancer Commons and PanCAN Collaborate to Help Pancreatic Cancer Patients

    Cancer Commons is excited to share our latest collaboration with the Pancreatic Cancer Action Network (PanCAN). The purpose of the grant-funded project is for Cancer Commons to help pancreatic cancer patients referred by PanCAN achieve their best possible treatment outcomes and enroll in a longitudinal study assessing individualized therapies and contributing to improved outcomes for future pancreatic cancer patients. Patients will be entered in… Read more »

  • Text reads WEBINAR: Testing Matters - Understanding Cancer Biomarker Testing and How it Applies to You. over photos of Cancer Commons Scientists Kaumudi Bhawe, PhD, and Adrienne Nugent, PhD.
    Cancer Commons Presents Free Webinar on Biomarker Testing and Why it Matters

    We invite everyone to join an upcoming webinar focused on helping cancer patients and caregivers understand molecular testing, the strengths and limitations of each kind, and how testing can be used to understand and help with your or your loved one’s particular cancer. Testing Matters—Understanding Cancer Biomarker Testing and How It Applies to You, will be offered virtually and free of charge on September 14, 2022, at… Read more »

  • I am grateful for the concise and accurate summary of my treatment options. I have been waiting 3 years for this. Your goal to close the gap between metastatic trials and patients holds great promise to speed up success.

    Michelle Kendall
    Cancer patient

  • Glioblastoma is devastating, and Cancer Commons made excellent recommendations to present to our medical team. They know what they are doing and have the experts that can sift through the voluminous mountain of research.

    Glory Cochrane
    Wife of glioblastoma patient

  • I had never reached out to anyone else besides my oncologist’s team. I was so shocked that I did not know about you. No one ever brought up trials with me. Cancer Commons was the first and only. The National Cancer Institute should be funding you. Everyone should have access to Cancer Commons.

    Michelle Kendall
    Cancer Patient

  • Clear information with caring follow-up.

    Sister of a pancreatic cancer patient

  • Cancer Commons helped give me peace of mind with my treatment decision. Chief scientist Emma Shtivelman’s expert, science-based opinion made such logical sense, and it also felt right in my soul.

    Breast cancer patient